Skip to main content
Fig. 4 | Trials

Fig. 4

From: Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations

Fig. 4

Current enrollment. As of Dec 14, 2020, there have been 319 patients enrolled among 2005 screened (16% enrollment) at 21 hospitals, after excluding those who were not candidates due to age < 18 years, not suspected to have COVID-19, unlikely to be admitted for more than 24 h due to either discharge or death, or having previously participated in REMAP COVID in the previous 90 days. The one patient enrolled at UPMC Children’s Hospital was older than 18 years of age but maintained longitudinal care with clinicians at Children’s

Back to article page

Trials

ISSN: 1745-6215